Editorial commentary: Emerging problems impeding the elimination of the last polioviruses: Silent circulation of wild strains in a well-immunized population

Clinical Infectious Diseases

Volumn 60, Issue 7, 2015, Pages 1065-1067

  Delpeyroux, Francis ^a,b   Colbère Garapin, Florence ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

Author keywords

environmental surveillance; eradication; poliomyelitis; vaccine

Indexed keywords

MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

AFGHANISTAN; ANTIBODY TITER; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE ELIMINATION; DISEASE SURVEILLANCE; DRUG ANTIGENICITY; EPIDEMIC; ESTONIA; FINLAND; FLACCID PARALYSIS; HUMAN; HUMAN POLIOVIRUS 1; IMMUNE RESPONSE; INDIA; ISRAEL; MORTALITY; NIGERIA; NONHUMAN; NOTE; PAKISTAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; SEROCONVERSION; SEWAGE; VACCINATION; VIRAL CLEARANCE; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; WORLD HEALTH ORGANIZATION; ANIMAL; CLASSIFICATION; FECES; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; VIROLOGY;

ANIMALS; ENVIRONMENTAL MICROBIOLOGY; FECES; FEMALE; HUMANS; MALE; POLIOVIRUS;

EID: 84926660468     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu1139     Document Type: Note

References (10)

1. Pallansch MA, Roos R. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Knipe DM, Howley PM, eds. Fields virology. 5th ed. Vol 1. Philadelphia: Lippincott Williams & Wilkins, 2007:839-94.
2. Combelas N, Holmblat B, Joffret ML, Colbere-Garapin F, Delpeyroux F. Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence. Viruses 2011; 3:1460-84.
3. Kew OM, Cochi SL, Jafari HS, et al. Possible eradication of wild poliovirus type 3-worldwide, 2012. MMWR Morb Mortal Wkly Rep 2014; 63:1031-3.
4. Hovi T, Shulman LM, van der Avoort H, Deshpande J, Roivainen M, EM DEG. Role of environmental poliovirus surveillance in global polio eradication and beyond. Epidemiol Infect 2012; 140:1-13.
5. Shulman LM, Manor Y, Sofer D, et al. Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations. PLoS One 2006; 1:e69.
6. Anis E, Kopel E, Singer SR, et al. Insidious reintroduction of wild poliovirus into Israel, 2013. Euro Surveill 2013; 18:20586.
7. Shulman L, Gavrilin E, Jorba J, et al. Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013. Euro Surveill 2014; 19:20709.
8. Drexler JF, Grard G, Lukashev AN, et al. Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010. Proc Natl Acad Sci U S A 2014; 111:12889-94.
9. Patel MK, Konde MK, Didi-Ngossaki BH, et al. An outbreak of wild poliovirus in the Republic of Congo, 2010-2011. Clin Infect Dis 2012; 55:1291-8.
10. Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog 2012; 8:e1002599.